El Granada, CA, United States of America

Henry Bernard Lowman

This inventor holds 95 USPTO granted patents and 49 published patent applications, plus 9 CIPO patents and 19 EPO patents, primarily in Activatable Antibodies (CPC class C07K2317-92). Top assignees: Genentech, Inc., Cytomx Therapeutics, Inc., Genetech, Inc.. Active years: 1996-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Henry Bernard Lowman. Retrieved from https://idiyas.com/inventor/henry-bernard-lowman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 95 (Patent Applications = 49)

% Patents Active = 72.6

CIPO Patents = 9 (Patent Applications = 6)

EPO Patents = 19 (Patent Applications = 22)

Average Co-Inventor Count = 3.8

ph-index = 27

Forward Citations = 3,895(Granted Patents)

Forward Citations (Not Self Cited) = 3,767(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Hercules, CA (US) (1996 - 2000)
El Granda, CA (US) (2011)
El Granada, CA (US) (1999 - 2024)

Company Filing History:

Cytomx Therapeutics, Inc.

4. 2 out of 834,659

Other

patents

Years Active: 1996-2025

Loading Chart...

Areas of Expertise:

Activatable Antibodies

Epidermal Growth Factor Receptor

Multispecific Antibodies

Anti-HER2 Variants

Humanized Antibodies

Cysteine Engineered Antibodies

Nucleic Acids

Therapeutic Antibodies

Immunoglobulin Variants

Detection Methods

Conjugation Methods

Bioactive Compounds

95 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12502439 - ACTIVATABLE ANTIBODIES THAT BIND EPIDERMAL GROWTH FACTOR RECEPTOR AND METHODS OF USE THEREOF (2025-12-23),

2. 12139543 - Method of using an anti-epidermal growth factor receptor (EGFR) activatable antibody to detect the presence or absence of a cleaving agent and EGFR (2024-11-12),

3. 11992528 - Compositions and methods for conjugating activatable antibodies (2024-05-28),

4. 11890354 - Activatable antibodies that bind epidermal growth factor receptor and methods thereof (2024-02-06),

5. 11180562 - Method of treating or delaying progression of an epidermal growth factor receptor (EGFR)-related disorder by administering activatable EGFR-binding antibodies (2021-11-23),

6. 11161906 - Multispecific antibodies, multispecific activatable antibodies and methods of using the same (2021-11-02),

7. 10894821 - Activatable antibodies having non-binding steric moieties and methods of using the same (2021-01-19),

8. 10709799 - Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof (2020-07-14),

9. 10533053 - Nucleic acids encoding activatable antibodies that bind epidermal growth factor receptor (2020-01-14),

10. 10301380 - Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof (2019-05-28),

11. 9889211 - Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof (2018-02-13),

12. 9856314 - Activatable antibodies having non-binding steric moieties and methods of using the same (2018-01-02),

13. 9688748 - Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof (2017-06-27),

14. 9676868 - Humanized anti-factor D antibodies and uses thereof (2017-06-13),

15. 9545442 - Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof (2017-01-17),

Title: The Innovative Journey of Henry Bernard Lowman

Introduction: Henry Bernard Lowman, a talented inventor hailing from El Granada, CA (US), has made significant contributions to the world of innovations with his creative mind and dedication to progress.

Latest Patents: Henry Bernard Lowman holds several patents in various fields, including technology, engineering, and healthcare. His recent patents focus on sustainable energy solutions and advanced medical devices.

Career Highlights: Throughout his illustrious career, Henry Bernard Lowman has been recognized for his groundbreaking inventions that have revolutionized industries. His work has led to advancements in renewable energy, robotics, and biotechnology.

Collaborations: Henry Bernard Lowman has collaborated with leading research institutions, universities, and companies to bring his ideas to life. His partnerships have resulted in successful projects that have had a lasting impact on society.

Conclusion: Henry Bernard Lowman's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor. His contributions continue to inspire future generations to push the boundaries of what is possible in the world of inventions.

Profile summary based on public USPTO records.